Navigation Links
Alexion Reports Fourth Quarter and Full Year 2007 Results
Date:2/14/2008


Soliris(R) Sales Reflect Strong 2007 Launch; Positioned for Expanded Growth in
U.S. and International Markets

Fourth Quarter and 2007 Financial Highlights:

* Soliris(R) (eculizumab) net product sales were $33.9 million in Q4 2007,

compared to net product sales of $21.8 million in Q3 2007.

* Q4 GAAP net loss was $12.3 million, or $0.33 per share, compared to a

GAAP net loss of $20.1 million, or $0.55 per share, in Q3 2007.

* Q4 non-GAAP net loss was $8.5 million, or $0.23 per share, compared to a

non-GAAP net loss of $14.0 million, or $0.38 per share, in Q3 2007.

* Total 2007 revenues were $72.0 million, including Soliris net product

sales of $66.4 million, representing the first nine months of Soliris

commercial availability.

* 2007 GAAP net loss was $92.3 million, or $2.54 per share, compared to a

net loss of $131.5 million, or $4.15 per share, in 2006.

* 2007 non-GAAP net loss was $72.1 million, or $1.99 per share, compared

to a net loss of $110.9 million, or $3.50 per share, in 2006.

CHESHIRE, Conn., Feb. 14 /PRNewswire-FirstCall/ -- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced financial results for the quarter and year ended December 31, 2007.

Fourth Quarter 2007 Financial Results:

For the three months ended December 31, 2007, Alexion Pharmaceuticals, Inc. ("Alexion" or, the "Company") reported revenues of $33.9 million compared to revenues of $0.2 million for the same period in 2006. The revenues of $33.9 million for the fourth quarter of 2007 consisted entirely of Soliris(R) net product sales, compared to Soliris net product sales of $21.8 million in the third qu
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Alexion to Present at Bear Stearns Healthcare Conference
2. Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast
3. Alexion Acquires All Rights to OMRF Patents Related to Soliris(R)
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. QMed, Inc. Reports July Medicare SNP Enrollments
6. Phlo Affiliate Reports Expanded Coverage to Oregon Border
7. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
8. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
9. Carrington Reports Second Quarter 2007 Results
10. Avitar Reports Third Quarter Financial Results for Fiscal 2007
11. Response Genetics Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Calif. , March 2, 2015 ... company developing therapies for autoimmune and infectious diseases, ... (USPTO) has issued an important new composition of ... function through the targeting of CLIP. ... peptide technology underlying VG Life Sciences, VG1177, a ...
(Date:3/2/2015)... 02, 2015 Outside GC, the leading ... the addition of Debbie Casey as a member of ... healthcare space. , Debbie has spent over ... with Fresenius Medical Care North America in both legal ... experience to work with Outside GC’s growing list of ...
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine” or ... a fraudulent press release disseminated this morning by PR ... Immunovaccine. This press release states that Immunovaccine has entered ... The press release did not originate from Immunovaccine and ... the press release. Please note that all official ...
(Date:2/27/2015)... CAMBRIDGE, Mass. , Feb. 27, 2015 /PRNewswire-USNewswire/ ... Analysis of the NCATS rare-diseases portfolio " in ... of a new financing technique to reduce the ... new diseases and potentially unlock new levels of ... The product of a unique collaboration between ...
Breaking Biology Technology:VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Outside GC Expands Healthcare Team 2Immunovaccine Disclaims Hoax Press Release 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4
... businesses seek to protect and enhance the value of ... of the business' products and services. Each year, several ... of them for federal trademark registration. Indeed, applications for ... leading indicator of economic conditions (a steep drop in ...
... Search engine experts have been hounding Google to accept XML ... When Google recently introduced the beta version of Google ... - at least in part. , ,Google Sitemaps is a ... with frequently updated or changing content. It ensures that the ...
... for the first time, China has 100 million people on ... a few years, a billion people in Asia will be ... replicating at a phenomenal rate will create global shockwaves both ... including India and several other highly populated countries, is not ...
Cached Biology Technology:Why file for trademark protection? 2Why file for trademark protection? 3Why file for trademark protection? 4Givin' it to Google: Using an XML Sitemap to Boost Your Site 2Givin' it to Google: Using an XML Sitemap to Boost Your Site 3Huge cyber-tsunami developing in Asia 2Huge cyber-tsunami developing in Asia 3
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America recently ... for carbon nanotube (CNT) macrostructures, including sheets, yarns and ... (UTD). Leveraging the vast industrial resources of ... Japan , Lintec of America is forming the ... TX , focusing on scaling up the manufacturing ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... Khalid Iqbal Lifetime Achievement Award" for its role as ... disease. The award ceremony was held yesterday (10:45 am ... International Conference (AAIC 2013)" in Boston (USA). Eva-Maria ... progress in Alzheimer,s research in the course of their ...
... avian H7N9 influenza that emerged in China this year have ... the infection, but testing for antiviral resistance can give misleading ... The authors of a study published in mBio , ... characterized viruses taken from the first person known to be ...
... -- United Medical Education, a leading online certifying institution ... Pediatric Advanced Life Support (PALS), and Basic Life Support ... course materials for its ACLS online renewal ... online courses. (Photo: http://photos.prnewswire.com/prnh/20130715/MN47087 ) ...
Cached Biology News:Pioneers in Alzheimer's research: Research couple honored for its lifetime achievement 2Pioneers in Alzheimer's research: Research couple honored for its lifetime achievement 3H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance 2H7N9 influenza strain resistant to antivirals, but tests fail to identify resistance 3ACLS Online Renewal Course from United Medical Education Now Features Newly-Updated Course Materials 2
alpha-N-Catenin Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Bovine Endometrium Epithelial Cells (BEnEpC) (>500,000 cells)...
... Darkroom is designed for imaging of chemiluminescent, ... systems offer direct control for users who ... by hand , A range of high ... for all fluorescent and chemiluminescent applications ...
... smooth muscle cell specific protein, is reported to ... such as intestine, lung and uterus. It shares ... alpha expression has been reported in most tissues ... visceral forms. It is also reported to be ...
Biology Products: